Fig. 2From: ‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironmentDURVIT study flowchart. DLT = dose limiting toxicity, SAE = serious adverse event, MTD = maximum tolerated doseBack to article page